The major averages are nearing the 50 and 200 averages. When they clear those averages, look for a new round of buying. Investors will be looking to buy those stocks that have been beaten up the most in this correction. FEYE is in that category.
Some folks probably got a heads-up on this on Friday. That accounts for the lack of movement on what was a solid market up day.
Was that downgrade before or after the FFIV partnership? Seems that investors only give credence to information that supports the decision they have already made. Yup, applies to me too sometimes.
Day is not done. Passive short positions may find themselves scrambling to close positions. Who knows what sort of news might come out over the weekend.
They never mention any money exchanging hands in these partnership announcements. Get used to it. When they do report financials, they still won't report any specifics.
Sell to a big company? Why would Berlin and the board want to do that? Right now Berlin is paid the equivalent of 200K of ROSG shares.
I didn't even bother to read the PR. I know from experience that doesn't have any money specified (perhaps because ROSG has to pay out some cash) and a week from now it'll be little more than evidence that the doors are still open. Looks like that is market sentiment too: no change on a huge up market day and only 45K shares traded.
China promises not to engage in cyber-theft of intellectual property. Good enough. I guess we can dump all of our security software. At least that is what the sellers of FEYE are saying today.
From 360 to 365 by Jefferies. How much research and analysis did it take to increase the target by less than 2%? They must be pretty confident in their forecast to change it by $5. Personally, I think their target is conservative. My target, based on 3 minutes of research, is $365.95.
Oversold and will turn up despite a weak market. Should finish up 7%.
No reason to buy the small players. If Clinton's idea becomes law, the value of the small caps will crash and the cost of development will far exceed the potential revenue. Only the "mainstream" illnesses with huge populations will be able to support new drugs. If you have an orphan illness, you're out of luck if you're hoping for a new cure.
Ms. Clinton has a plan to control the costs of drugs. That means the small companies will suffer since the potential for profitable new drugs is lowered and investment in small companies will be reduced as well. The big companies will be OK since they have the internal resources to comply with gov't regulations and without new competition from the small companies, the big boys will be just fine. It will be just like the marriage of health insurance companies and Obamacare.
DDD is holding up relatively well in this down market. Seems to be clinging to that 12.50 option strike. I forgot about that; I remember when options strikes were always whole numbers and in fact, nice round numbers like 10 and 15.
Frankly, I'm losing interest in ROSG. There are so many other market opportunities that are much less dependent upon a hoped for bounce from a multi-year bottom. If price goes up $1, it still isn't noteworthy from a long term perspective.
And you're trying to get people to dump at the low. You're not selling at the current price. Instead, you are either hoping for a lower price to cover or open a long position. Just like an analyst (on a micro-scale), you have established your position and then give your recommendation.
What kind of luck? Seems that everyone who bought in the last 24 hours had bad luck and those who sold had good luck. Is this another company that releases good news and longs feel lucky to get out at a slightly higher price and thereby cut their losses?